Dr. Oloumi recieved her PhD in Cancer Biology in 2002 from the Department of Pathology and Laboratory Medicine at the University of British Columbia for her work on Cell-cell contact induced resistance to etoposide. She the joined BC Cancer as a Postdoctoral Fellow and Research Associate. In 2010 she was made Staff Scientist and Project Manager for the Aparicio Lab. Since leaving the Aparicio Lab in 2015, Dr. Oloumi has worked at the Janssen Pharmaceurical Companies of Johnson & Johnson and Bristol Myers Squibb. She is currently the Scientific Advisor for Mesothelioma for Bristol Myers Squibb.